Skip to main content
. 2014 Jul 7;5(15):6113–6129. doi: 10.18632/oncotarget.2176

Figure 9. A proposed model for miR-451/c-Myc-rad-51/survivin signaling pathway in chemo- and radiotherapy cross resistance in LAD cells.

Figure 9

Docetaxel-resistant LAD cells acquired radioresistant phenotype where miR-451 was downregulated, resulting in chemo- and radiotherapy cross resistance.